LESLIE HINDS: Open Payments
NPI 1649310244 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 67 payments from 28 companies in 2025. Trend: 2023 $2,227 · 2024 $1,781 · 2025 $1,572
Food & beverage: $1,479Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $233 |
| Gilead Sciences, Inc. | 6 | $176 |
| Daiichi Sankyo Inc. | 9 | $135 |
| GlaxoSmithKline, LLC. | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| EMD Serono, Inc. | 3 | $86 |
| Genentech USA, Inc. | 3 | $73 |
| Karyopharm Therapeutics Inc. | 2 | $55 |
| Eisai Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $52 |
Products named: Trodelvy, ERLEADA, Enhertu, JEMPERLI, XPOVIO, Lenvima, VERZENIO, CABOMETYX.
Industry payments across CO — which companies pay providers there.
